CARMI, Caterina
 Distribuzione geografica
Continente #
EU - Europa 770
NA - Nord America 702
AS - Asia 304
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.801
Nazione #
US - Stati Uniti d'America 685
CN - Cina 227
FI - Finlandia 188
SE - Svezia 136
IE - Irlanda 130
IT - Italia 128
DE - Germania 76
UA - Ucraina 66
TR - Turchia 28
AT - Austria 25
CI - Costa d'Avorio 24
IN - India 21
SG - Singapore 21
CA - Canada 17
BE - Belgio 12
CZ - Repubblica Ceca 6
JP - Giappone 2
KR - Corea 2
VN - Vietnam 2
EU - Europa 1
GB - Regno Unito 1
IR - Iran 1
LU - Lussemburgo 1
RO - Romania 1
Totale 1.801
Città #
Chandler 161
Dublin 130
Jacksonville 89
Parma 77
Ann Arbor 68
Dearborn 54
Beijing 49
Ashburn 43
Shanghai 36
Nanjing 29
Izmir 27
San Mateo 27
Vienna 25
Abidjan 24
Princeton 23
New York 22
Wilmington 17
Pune 15
Toronto 15
Helsinki 14
Shenyang 14
Bremen 13
Kunming 12
Brussels 11
Hefei 11
Los Angeles 11
Boardman 10
Hebei 10
Nanchang 10
Düsseldorf 9
Singapore 8
Jinan 7
Prata Di Pordenone 7
Tianjin 7
Brno 6
Des Moines 5
Ardea 4
Changsha 4
Jiaxing 4
Montegaldella 4
Fremont 3
Fuzhou 3
Seattle 3
Zhengzhou 3
Augusta 2
Borås 2
Dong Ket 2
Highland Park 2
Houston 2
Lübeck 2
Milan 2
Norwalk 2
Reggio Nell'emilia 2
Ulsan 2
Xian 2
Ankara 1
Atlanta 1
Braunschweig 1
Caorso 1
Casalgrande 1
Chengdu 1
Chongqing 1
Chuxiong 1
Esslingen am Neckar 1
Fornovo Di Taro 1
Frankfurt am Main 1
Geislingen an der Steige 1
Grafing 1
Guangzhou 1
Haikou 1
Hangzhou 1
Huzhou 1
Lanzhou 1
Leuven 1
Lissone 1
Luxembourg 1
Montreal 1
Mumbai 1
Munich 1
Ningbo 1
Quzhou 1
Redmond 1
Rome 1
Sassuolo 1
Taizhou 1
Taranto 1
Tokyo 1
Utsunomiya 1
Woodbridge 1
Totale 1.180
Nome #
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines 132
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 105
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 101
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 98
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 89
Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion 88
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability 86
Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria 85
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 85
Antiproliferative and proapototic effects of a new combi-molecule on non small cell lung cancer cell lines 82
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 80
A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors. 78
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives. 77
Clinical perspective for irreversible tyrosine kinase inhibitors in cancer 75
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands 72
New strategies to overcome resistance to EGFR tyrosine kinase inhibitors in non small cell lung cancer 69
Irreversible EGFR inhibitor compounds with antiproliferative activity 67
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 66
Epidermal Growth Factor Receptor Irreversible Inhibitors: Chemical Exploration of the Cysteine-Trap Portion 65
Mannich base derivatives as novel EGFR irreversible inhibitors 55
Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitors 51
Solution Phase Parallel Synthesis of S-DABO Analogues 48
Parallel Solution-Phase Synthesis of 1,5-disubstitued Hydantoins as New Protein Tyrosine Kinase Inhibitors 41
Parallel Solution-phase and Microwave-assisted Synthesis of New S-DABO Derivatives Endowed with Subnanomolar Anti-HIV-1 Activity 38
Totale 1.833
Categoria #
all - tutte 5.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020335 47 64 18 2 28 37 46 8 27 26 9 23
2020/2021221 1 18 30 2 34 12 28 8 35 10 27 16
2021/2022144 6 9 5 7 7 2 22 23 7 13 10 33
2022/2023576 58 73 45 53 60 67 5 33 157 3 15 7
2023/2024192 12 11 1 5 12 60 22 14 5 9 14 27
2024/202528 28 0 0 0 0 0 0 0 0 0 0 0
Totale 1.833